S G Wannamethee1, P H Whincup, A Rumley, G D O Lowe. 1. Department of Primary Care and Population Sciences, Royal Free and University College Medical School, London, UK. goya@pcps.ucl.ac.uk
Abstract
OBJECTIVES: Interleukin-6 (IL-6) has been implicated in the development of cardiovascular disease. We have examined the relationship between plasma IL-6 and insulin resistance, and metabolic, inflammatory and hemostatic markers. METHODS: We examined 3490 men aged 60-79 years who were drawn from general practices in 24 British towns. The men were not diabetic and were not taking warfarin. RESULTS: IL-6 was significantly associated with age, body mass index (BMI), waist circumference (WC), cigarette smoking, low physical activity, social class and alcohol intake (U-shaped). IL-6 showed no association with insulin resistance or its other components (blood glucose, triglycerides, blood pressure) except high-density lipoprotein-cholesterol (inversely), and no association with hematocrit, factor (F) VII or adiponectin after adjustment for age and WC. IL-6 was strongly associated with markers of inflammation (C-reactive protein, fibrinogen, white cell count); plasma viscosity; elevated markers of coagulation (fibrin D-dimer, FVIII, FIX); markers of endothelial dysfunction (von Willebrand factor, tissue plasminogen activator); and to a smaller extent with platelet count, APC ratio and gamma glutamyltransferase. Risk of the metabolic syndrome increased significantly with increasing IL-6 but was attenuated after adjustment for BMI. CONCLUSION: IL-6 may have a potential role as a mediator between cardiovascular risk factors and several biological mechanisms for cardiovascular disease.
OBJECTIVES:Interleukin-6 (IL-6) has been implicated in the development of cardiovascular disease. We have examined the relationship between plasma IL-6 and insulin resistance, and metabolic, inflammatory and hemostatic markers. METHODS: We examined 3490 men aged 60-79 years who were drawn from general practices in 24 British towns. The men were not diabetic and were not taking warfarin. RESULTS:IL-6 was significantly associated with age, body mass index (BMI), waist circumference (WC), cigarette smoking, low physical activity, social class and alcohol intake (U-shaped). IL-6 showed no association with insulin resistance or its other components (blood glucose, triglycerides, blood pressure) except high-density lipoprotein-cholesterol (inversely), and no association with hematocrit, factor (F) VII or adiponectin after adjustment for age and WC. IL-6 was strongly associated with markers of inflammation (C-reactive protein, fibrinogen, white cell count); plasma viscosity; elevated markers of coagulation (fibrin D-dimer, FVIII, FIX); markers of endothelial dysfunction (von Willebrand factor, tissue plasminogen activator); and to a smaller extent with platelet count, APC ratio and gamma glutamyltransferase. Risk of the metabolic syndrome increased significantly with increasing IL-6 but was attenuated after adjustment for BMI. CONCLUSION:IL-6 may have a potential role as a mediator between cardiovascular risk factors and several biological mechanisms for cardiovascular disease.
Authors: Jeanette M Bennett; Ronald Glaser; Rebecca R Andridge; Juan Peng; William B Malarkey; Janice K Kiecolt-Glaser Journal: Psychoneuroendocrinology Date: 2012-06-21 Impact factor: 4.905
Authors: Esmé Jansen van Vuren; Leoné Malan; Roland von Känel; Marike Cockeran; Nicolaas T Malan Journal: Hypertens Res Date: 2016-05-12 Impact factor: 3.872
Authors: Sarah C Van Alsten; Charles S Rabkin; Norie Sawada; Taichi Shimazu; Hadrien Charvat; Taiki Yamaji; Manami Inoue; Troy J Kemp; Ligia A Pinto; M Constanza Camargo; Shoichiro Tsugane; Minkyo Song Journal: Cancer Epidemiol Biomarkers Prev Date: 2020-05-28 Impact factor: 4.254
Authors: Mary-Frances O'Connor; Julie E Bower; Hyong Jin Cho; J David Creswell; Stoyan Dimitrov; Mary E Hamby; Michael A Hoyt; Jennifer L Martin; Theodore F Robles; Erica K Sloan; Kamala S Thomas; Michael R Irwin Journal: Brain Behav Immun Date: 2009-04-21 Impact factor: 7.217
Authors: Jian Shen; Donna K Arnett; Pablo Pérez-Martínez; Laurence D Parnell; Chao-Qiang Lai; James M Peacock; James E Hixson; Michael Y Tsai; Robert J Straka; Paul N Hopkins; José M Ordovás Journal: J Lipid Res Date: 2008-04-16 Impact factor: 5.922
Authors: Paul J Mills; Sonia Ancoli-Israel; Roland von Känel; Brent T Mausbach; Kirstin Aschbacher; Thomas L Patterson; Michael G Ziegler; Joel E Dimsdale; Igor Grant Journal: Brain Behav Immun Date: 2008-10-04 Impact factor: 7.217
Authors: Stacey E Alexeeff; Andrea A Baccarelli; Jaana Halonen; Brent A Coull; Robert O Wright; Letizia Tarantini; Valentina Bollati; David Sparrow; Pantel Vokonas; Joel Schwartz Journal: Int J Epidemiol Date: 2013-02 Impact factor: 7.196